DELTINGPHARM LTD
- 86900Other human health activities
Opportunity 82/100 (exceptional), bankability 85/100. Strong seller-intent signal (70/100, director aged 60). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Refinance opportunity
1 live charge · oldest 13.9y
Refinance would be pressure-driven, not opportunity-driven. Expect tighter margins and covenant scrutiny.
- · Oldest live charge is 13.9 years old — likely at or near maturity.
- · Single lender — cleanest path to refinance.
- · Distress signals active — lender appetite narrows.
Data confidence
Overall: medium (73/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 102| Metric | 2024-08-31 |
|---|---|
| Average employees | 11 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 2 accounts
Corporate timeline (21 events)Click to expand
- 2026-02-11📄change-account-reference-date-company-previous-extendedaccounts · AA01
- 2026-02-10📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-11-15📄gazette-filings-brought-up-to-dategazette · DISS40
- 2025-10-28📄gazette-notice-compulsorygazette · GAZ1
- 2024-07-03📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-11-04📄gazette-filings-brought-up-to-dategazette · DISS40
- 2023-11-01📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-10-31📄gazette-notice-compulsorygazette · GAZ1
- 2022-12-01📄gazette-filings-brought-up-to-dategazette · DISS40
- 2022-11-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-11-10📄dissolved-compulsory-strike-off-suspendeddissolution · DISS16(SOAS)
- 2022-10-25📄gazette-notice-compulsorygazette · GAZ1
- 2022-05-18📄change-person-director-company-with-change-dateofficers · CH01
- 2022-05-18📄mortgage-satisfy-charge-fullmortgage · MR04
- 2022-05-18🔓Charge satisfied #1
- 2021-05-24📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-05-18📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-05-13📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2012-07-10🔒Charge registered #1Lender: The Royal Bank of Scotland PLC
- 2010-08-03🏢Company incorporatedAs DELTINGPHARM LTD
- 2010-08-03➕SCOTT, Paul Andrew, Dr appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Long-tenure founder: Senior director has been in place 16 years — deep operational knowledge concentrated in one person.
- +Senior director age: Director aged approximately 60 — approaching natural succession window.
- +No director turnover: Company is 16 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- secondaryFounder aged 58+: Senior director is approximately 60. Early succession window.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 16 years.
- secondaryStable-but-static management: Company is 16 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Paul Andrew Scott Individual · British · DOB 01/1966 · age 60 | 75–100% | — | 75-100% shares | 03/08/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · ZE postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| SHETLAND CARE ATTENDANT SCHEME LTD→ SC172153 · est 1997 | — | — | — | 3200 | 29y | 81 | 77y |
| HAME FAE HAME LIMITED→ SC345090 · est 2008 | — | — | £18.2k | — | 17y | 80 | 66y |
| ICARE SHETLAND LTD→ SC238603 · est 2002 | — | — | £145.7k | — | 23y | 74 | 47y |
| C KELLY HOLDINGS LIMITED→ SC573225 · est 2017 | — | — | £501.0k | — | 8y | 73 | 47y |
| BIGTON COLLECTIVE LTD→ SC707956 · est 2021 | — | — | — | 2 | 4y | 72 | 73y |
| CALLISTO HEALTH LTD→ SC770110 · est 2023 | — | — | — | — | 2y | 71 | 36y |
| DA MAD HOOSE LTD→ SC703996 · est 2021 | — | — | £470 | — | 4y | 71 | 25y |
| DEMIRA LTD→ SC713229 · est 2021 | — | — | — | — | 4y | 71 | 35y |
| JEEVA MEDICS LIMITED→ SC862754 · est 2025 · no financials extracted | — | — | — | — | — | 71 | 51y |
| ML REPORTS LTD→ SC872472 · est 2025 · no financials extracted | — | — | — | — | — | 71 | 41y |
| 60 NORTH PSYCHOLOGY LTD→ SC707943 · est 2021 | — | — | — | 100 | 4y | 70 | 49y |
| DIADENT LIMITED→ SC780736 · est 2023 | — | — | — | — | 2y | 70 | 30y |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.
Mortgages & charges
| Type | Properties | |||||
|---|---|---|---|---|---|---|
| satisfied | Lloyds Banking Group The Royal Bank of Scotland PLC | Floating charge | 1 property | 10/07/2012 | 18/05/2022 |